Form 15-12G Elevation Oncology, Inc.

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. IBM
2. JPM
3. TREX
4. BAC
5. SPY
6. WFC
7. ERAS
8. SPCX
9. SPRO
10. TSCO

August 4, 2025 4:35 PM EDT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 15
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
001-40523
Commission File Number

ELEVATION ONCOLOGY, INC.
(Exact name of registrant as specified in its charter)

101 Federal Street, Suite 1900
Boston, MA 02110
(716) 371-1125
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, $0.0001 par value per share
(Title of each class of securities covered by this Form)

 None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
 
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
 
Rule 12g-4(a)(1)
☒
 
Rule 12g-4(a)(2)
☐
 
Rule 12h-3(b)(1)(i)
☒
 
Rule 12h-3(b)(1)(ii)
☐
 
Rule 15d-6
☐
 
Rule 15d-22(b)
☐

Approximate number of holders of record as of the certification or notice date:
One

Pursuant to the requirements of the Securities Exchange Act of 1934, Elevation Oncology, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
 
Date: August 4, 2025
ELEVATION ONCOLOGY, INC.
   
 
By:
 /s/ Michael Hearne
   
Name: Michael Hearne
   
Title: Chief Financial Officer



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings